CYP3A inhibitors
Showing 1 - 25 of >10,000
B-cell Malignancies Trial in Australia (Zanubrutinib, Fluconazole, Diltiazem)
Completed
- B-cell Malignancies
- Zanubrutinib
- +4 more
-
Concord, New South Wales, Australia
- +6 more
Jul 18, 2022
Healthy Trial (Sildenafil, Erythromycin, Itraconazole)
Completed
- Healthy
- Sildenafil
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 25, 2022
Drug Interactions Trial in Austin (CYP450 Cocktail and Transporter Substrates with Pacritinib, Part 2 -Group A Bosentan 125 mg
Recruiting
- Drug Interactions
- CYP450 Cocktail and Transporter Substrates with Pacritinib
- +2 more
-
Austin, TexasPPD - Austin Research Unit
Jan 13, 2023
Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)
Not yet recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Vesatolimod
- +3 more
- (no location specified)
Jul 11, 2022
Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)
Completed
- Relapsed or Refractory Lymphoma
- Itraconazole 200 mg
- +3 more
-
Miami, FloridaQPS- Miami
Jan 12, 2023
HIV Trial in Baltimore (VH4524184, Midazolam, Placebo)
Recruiting
- HIV Infections
- VH4524184
- +2 more
-
Baltimore, MarylandGSK Investigational Site
Jan 11, 2023
Healthy Volunteers Trial in Seoul (Midazolam, Clarithromycin, Grapefruit juice)
Completed
- Healthy Volunteers
- Midazolam
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 25, 2022
Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)
Active, not recruiting
- Relapsed or Refractory Lymphoma
- HMPL-523
- +2 more
-
Austin, TexasPPD Austin
Jan 31, 2023
Healthy Subjects, Drug-drug Interaction, Pharmacokinetics Trial in San Antonio (Efavirenz, Quizartinib)
Completed
- Healthy Subjects
- +3 more
-
San Antonio, TexasWorldwide Clinical Trials
Jun 3, 2022
Healthy Volunteers Trial (Brensocatib, Clarithromycin)
Not yet recruiting
- Healthy Volunteers
- (no location specified)
Jul 19, 2023
CYP3A4*22 Trial (Palbociclib 125Mg Tab, Ribociclib 200Mg Oral Tablet, Abemaciclib 150 MG Oral Tablet)
Not yet recruiting
- CYP3A4*22
- Palbociclib 125Mg Tab
- +2 more
- (no location specified)
Jan 10, 2023
Healthy Volunteers Trial in Tempe (TAK-279, Erythromycin, Phenytoin)
Not yet recruiting
- Healthy Volunteers
- TAK-279
- +3 more
-
Tempe, ArizonaCelerion - Tempe, AZ Site
Aug 9, 2023
CYP3A Inhibitor, Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma Trial in Heidelberg (Cobicistat Oral Tablet)
Not yet recruiting
- CYP3A Inhibitor
- Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma
- Cobicistat Oral Tablet
-
Heidelberg, BW, GermanyUniversity Hospital Heidelberg
Aug 10, 2022
Rheumatoid Arthritis Trial in Wuhan (SHR0302 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)
Completed
- Rheumatoid Arthritis
- SHR0302 Tablets
- +5 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Dec 21, 2022
Drug Interaction Trial in Uppsala (Drug Drug Interaction)
Recruiting
- Drug Interaction
- Drug Drug Interaction
-
Uppsala, SwedenCTC Clinical Trial Consultants AB
Apr 13, 2023
Breast Cancer Female, Hormone-receptor-positive Breast Cancer Trial in Lisboa (Brief Physical Activity Counselling, Structured
Recruiting
- Breast Cancer Female
- Hormone-receptor-positive Breast Cancer
- Brief Physical Activity Counselling
- Structured Exercise Program
-
Lisboa, PortugalUniversidade Lusófona, Campo Grande 376
May 5, 2023
Health Volunteers Trial in Miami (CTP-543, Fluconazole)
Recruiting
- Health Volunteers
-
Miami, FloridaClinical Pharmacology of Miami, LLC
Jul 26, 2022
Immunosuppression, Kidney Transplant Rejection, Kidney Transplant; Complications Trial in Warsaw (Tacrolimus, Unbound tacrolimus
Recruiting
- Immunosuppression
- +6 more
- Tacrolimus
- +2 more
-
Warsaw, PolandDepartment of General and Transplant Surgery, Medical University
Apr 14, 2022
Parkinson Disease Trial in Madison (Tavapadon, Carbamazepine)
Active, not recruiting
- Parkinson Disease
-
Madison, WisconsinMadison, Wisconsin
Jan 13, 2023
Relapsed/Refractory Large Granular T Lymphocytic Leukemia Trial in Zhoukou, Tianjin (Linperlisib)
Not yet recruiting
- Relapsed/Refractory Large Granular T Lymphocytic Leukemia
-
Zhoukou, Henan, China
- +1 more
Dec 22, 2022